Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Advanced Accelerator Applications completes €23mm late round

Executive Summary

Advanced Accelerator Applications (molecular nuclear medicine, diagnostics, and therapeutics) raised €23mm ($25.7mm) in what the company calls a crossover financing, led by Adage Capital Management. New investors included Rock Springs Capital Management and funds and accounts managed by Rock Springs Capital. Some of the proceeds will help the company continue Phase III work on its lead radiopharmaceutical Lutathera (Lu-177-labeled somatostatin analog) for neuroendocrine cancers.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies